Is Weed a Muscle Relaxer? What the Science Says

Cannabis does have muscle-relaxing properties, and the effect is real enough that a cannabis-based medication is approved in over 25 countries specifically for muscle spasticity. But the way weed relaxes muscles is different from how traditional muscle relaxants work, and the strength of the effect depends heavily on what you’re using it for, whether that’s a diagnosed condition like multiple sclerosis or general post-workout soreness.

How Cannabis Relaxes Muscles

Your body has a built-in system called the endocannabinoid system that helps regulate muscle tone, among many other things. When muscles are tight or spastic, the underlying problem is often too much signaling from excitatory nerve pathways. Glutamate, the brain’s main excitatory chemical messenger, keeps firing and telling muscles to contract when they shouldn’t be.

THC, the psychoactive compound in cannabis, activates receptors called CB1 receptors on nerve cells. When these receptors are activated, they reduce the release of glutamate, essentially turning down the volume on the “contract” signal reaching your muscles. This mechanism has been confirmed in animal studies where drugs that block CB1 receptors actually make spasticity worse, and where CB1-activating compounds have no effect in animals genetically lacking those receptors. The endocannabinoid system appears to play a natural role in keeping muscle tone in check. Researchers have found that this system is dysregulated both in animal models of spasticity and in the spinal fluid of people with multiple sclerosis.

THC and CBD Play Different Roles

THC is the primary driver of the muscle-relaxing effect. It directly binds to CB1 receptors in the central nervous system, particularly at the nerve junctions where excitatory signaling happens. At various doses, THC produces pain relief, muscle relaxation, appetite stimulation, and the “high” that limits how much people can comfortably take.

CBD works differently. It has little direct activity at CB1 receptors but interacts with pain-sensing receptors and slows the breakdown of your body’s own cannabinoids. Studies have shown CBD can have anti-inflammatory, muscle relaxant, and neuroprotective effects on its own. Perhaps its most useful role in a muscle-relaxing context is that it counteracts the psychoactive effects of THC, allowing people to tolerate higher, more effective doses of THC without feeling as impaired.

This is why the most studied cannabis-based muscle relaxant uses a 1:1 ratio of THC to CBD. The combination lets THC do the heavy lifting on spasticity while CBD moderates the mental side effects and adds its own therapeutic benefits.

What the Clinical Evidence Shows

The strongest evidence for cannabis as a muscle relaxer comes from multiple sclerosis research. In clinical trials, a THC-CBD oral spray was linked to a 51% reduction in MS-related spasticity compared to placebo, measured by patient-reported scales. Patients using the spray also showed statistically significant improvements on numerical rating scales for spasticity.

In animal studies comparing the THC-CBD combination directly to baclofen (one of the most commonly prescribed muscle relaxants), the cannabis-based treatment at higher doses matched baclofen’s effectiveness. Baclofen produced roughly a 40% peak reduction in limb stiffness, while the THC-CBD combination at its higher tested dose achieved the same 40% reduction. Both treatments took effect within 10 minutes and lasted at least two hours. At lower doses, the cannabis combination achieved about a 20% reduction, roughly half as effective as baclofen.

This medication, called nabiximols, is approved in over 25 countries including Canada, the United Kingdom, and France for MS-related spasticity. It is not currently approved in the United States, though clinical trials are ongoing.

Everyday Muscle Tension and Soreness

Most people searching this question probably aren’t dealing with MS. They want to know if smoking or taking cannabis will help with a sore back, tight shoulders, or post-exercise muscle pain. The honest answer is that the clinical evidence is much thinner here. Nearly all rigorous research has focused on neurological spasticity, not the kind of muscle tightness you get from sitting at a desk or lifting weights.

That said, the basic mechanism still applies. THC reduces excitatory nerve signaling regardless of whether the tightness stems from a neurological condition or from overworked muscles. Many people report subjective relief from muscle tension after using cannabis, and the pain-relieving properties of both THC and CBD likely contribute to the sensation of muscles “loosening up,” even if some of that effect is about perceiving less pain rather than a direct change in muscle tone.

CBD topicals are increasingly popular for localized muscle soreness, but the science is still catching up. For a topical to reach muscle tissue, it has to penetrate the outer skin layer and diffuse deeper over time. CBD is a fat-soluble molecule, which makes skin absorption inherently limited. Researchers describe the applicability of topical CBD for reaching skeletal muscle as “speculative yet hopeful.” Topicals bypass the bloodstream, meaning they won’t produce psychoactive effects, but their ability to deliver meaningful concentrations to deep muscle tissue remains unproven.

Side Effects to Expect

Cannabis is not a side-effect-free alternative to conventional muscle relaxants. In clinical studies of the THC-CBD spray, dizziness affected 25% of patients, drowsiness hit 8%, and disorientation occurred in 4%. About 12% of patients stopped treatment entirely because of side effects. Other commonly reported issues include dry mouth, fatigue, nausea, headache, confusion, and vision disturbances.

These numbers are worth keeping in mind if you’re comparing cannabis to something like baclofen or cyclobenzaprine, which carry their own sedation and dizziness risks. The side effect profiles overlap considerably. The main differentiator is that cannabis adds psychoactive effects that traditional muscle relaxants don’t produce, which can be either a benefit or a drawback depending on the person and the situation.

Dosing Is Harder Than You’d Think

One practical challenge with using cannabis for muscle relaxation is that dosing is inconsistent. THC and CBD concentrations vary enormously across products. Many dried cannabis products sold today contain 15% THC or higher, while the highest concentration studied in clinical settings is only 9.4%. Medical guidelines in the literature typically recommend starting with one inhalation of a low-potency product (9% THC maximum) once per day, gradually increasing to one inhalation four times daily, totaling about half a joint’s worth.

That’s a far cry from how most recreational users consume cannabis, which means the muscle-relaxing “sweet spot” may be a much smaller dose than people expect. Higher doses don’t necessarily mean more muscle relaxation. They often just mean more side effects, particularly cognitive impairment and sedation that can be mistaken for relaxation.